Growing evidence suggests that brain insulin resistance promotes or triggers key pathologies in AD [2,3,11,25–34], corresponding with the observed changes in levels of insulin signaling molecules in AD forebrains and associated declines in memory [2,11,12,27,32,34–36]. The gene discussed is INS; the disease is Alzheimer disease.